Research Site

Seongnam 463-707

1 studies enrolling now · 9 studies all time

What they study most

Advanced Clear Cell Renal Cell Carcinoma, Advanced Upper Gastrointestinal Tract Adenocarcinoma, Breast Cancer, EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Germline BRCA1/2 Mutations, HER2-ve Metastatic Breast Cancer, Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Non-Small-Cell Lung Carcinoma, Non-small Cell Lung Cancer, Somatic BRCA1/2 Mutations, Type 2 Diabetes Mellitus

Studies at this site

• Volrustomig Priming Regimens Exploratory Phase II Platform Study — Recruiting now
• Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma — Recruiting now
• A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body — Running, not enrolling
• Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma — Running, not enrolling
• A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer — Running, not enrolling
• A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib — Completed
• To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients. — Completed
• Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus — Completed
• ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures — Completed